Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2009 (Vol. 29, No. 1)

Invent Now

  • Programs
  • Needs more content
I guess the designers of this site decided that their opening page had to take the word “invent” to heart, so they created a novel interface to provide access to the content inside. As we all know, not every invention is a success, and the opening page is a poster child for it. When are designers going to learn that consistency combined with intuitiveness makes for a functional interface? OK, complaints aside, what are the offerings here? To start, Invent Now is a nonprofit organization that aims to foster the “spirit and practice” of invention. It sponsors the Collegiate Inventors Competition, an Inventors Hall of Fame, Camp Invention (for kids), an invention workshop, and a museum. Other information on the site includes descriptions of patents/how to patent, and a handful of useful links. Though I really like the programs the group offers, I’m disappointed that there is not more material on their website.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »